Area of research
Complementary and alternative medicine · Pharmacology
Research interest
Research interests include Chemistry, Pharmacology, Medicine, Chromatography, Pharmacokinetics, and Hyperlipidemia.
Integrated serum pharmacochemistry, pharmacokinetics, and network analysis to explore active components of BuShao Tiaozhi Capsule on hyperlipidemia
Mechanisms of Microctis Folium in Hyperlipidemia: Integrating Serum Pharmacochemistry, Network Pharmacology, and Transcriptomics
Corrigendum to “A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin” [Heliyon Volume 9, Issue 3, March 2023, Article e13598]
Integrating network toxicology and molecular docking to explore the toxicity of the environmental pollutant butyl hydroxyanisole: An example of induction of chronic urticaria
Comparison of ELSD and RID combined with HPLC for simultaneous determination of six rare sugars in food components
Investigation into the anti-inflammatory mechanism of Pothos chinensis (Raf.) Merr. By regulating TLR4/MyD88/NF-κB pathway: Integrated network pharmacology, serum pharmacochemistry, and metabolomics
ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways
Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model
A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin
Metabolomics analysis delineates the therapeutic effects of Yinlan Tiaozhi capsule on triton WR-1339 -induced hyperlipidemia in mice
Integrated network pharmacology and metabolomics reveal the mechanisms of Jasminum elongatum in anti-ulcerative colitis
Deciphering the mechanisms of Yinlan Tiaozhi capsule in treating hyperlipidemia by combining network pharmacology, molecular docking and experimental verification
Selection and evaluation of biomarkers of Gynostemma pentaphyllum (Thunb.) Makino representing its tonifying weakness and strengthening muscle effect based on PXR/IL-6/SERCA1a regulation
[Prediction and analysis of Q-markers of Elephantopus scaber based on its UPLC fingerprint, content determination of components, and in vitro a nti-tumor activity].
Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia
Metabolic Insight Into the Neuroprotective Effect of Tao-He-Cheng-Qi (THCQ) Decoction on ICH Rats Using Untargeted Metabolomics
The anti-hyperlipidemia effect of Yinlan capsule via regulation of PXR activity
Corrigendum to “Selection of quality markers of Jasminum amplexicaule based on its anti-diarrheal and anti-inflammatory activities: Effect-target affiliation-traceability-pharmacokinetics strategy” [Chinese Herbal Medicines 11 (2019) 379–386]
Selection and evaluation of quality control markers in propolis based on its hyperlipidemia therapy via regulating PXR/CYP3A4 expression
Selection and evaluation of quality markers from Yinlan capsule and its LXRα-mediated therapy for hyperlipidemia
Selection of quality markers of Jasminum amplexicaule based on its anti-diarrheal and anti-inflammatory activities: Effect-target affiliation-traceability-pharmacokinetics strategy
Pharmacokinetic based study on “lagged stimulation” of Curcumae Longae Rhizoma - Piper nigrum couplet in their main active components’ metabolism using UPLC-MS-MS
A fast and accurate method for the pharmacokinetic research of four coumarin analogs in <i>Fructus cnidii</i> using capillary electro‐chromatography with a methacrylate ester‐based monolithic column
Study on HPLC-fingerprint of Microcos paniculata
Zhongguo shiyan fangjixue zazhi 2012cited by 0position: first